Week of April 15th — On ‘PINS’ and Needles

Seven IPOs are on the calendar for this week coming from all kinds of sectors: Tech, Biotech, Energy and even Vaping (!).  

It’s the second time (Week of Feb 11th) that seven deals have been “scheduled” to price in a single week so far in 2019. That February week saw three of those deals postponed. That is “not-likely” to be the case this week with a more notable companies tapping the public markets. In all, the seven will likely raise more than $2.5bn collectively.

---

Brigham Minerals (MNRL) formed their company in 2012 to acquire and actively manage a portfolio of mineral and royalty interests in the core of what they view as the most active, highly economic, liquids-rich resource basins across the continental United States. 

Greenlane Holdings (GNLN) is a leading distributor of premium vaporization products and consumption accessories in the United States and have a growing presence in Canada. 

HOOKIPA Pharma  (HOOK) is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body’s immune system.

Turning Point Therapeutics (TPTX) is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients.

Palomar Holdings (PLMR) is a rapidly growing and profitable company focused on the provision of specialty property insurance. 

Pinterest Inc (PINS) is where more than 250 million people around the world go to get inspiration for their lives. At the midpoint of the range, Pinterest would raise $1.2bn in cash — the third $1bn+ IPO of 2019. 

Zoom Video Communications (ZM) provides a video-first communications platform that delivers happiness and fundamentally changes how people interact. 

---

If you are an active syndicate player and could find value in receiving daily color and commentary that comes DIRECTLY from the underwriter (subscription level, price guidance and book quality) please inquire about our services by emailing JZell@IPOBoutique.Com